Therefore, α-Synuclein in PD might act just like β-amyloids and tau in AD, as a facilitator and amplifier of PD by seeding pathology in the gut, ultimately affecting the brain (Braak et al., 2003; Kitani-Morii et al., 2021). This evidence concerns the gene MAPT and Parkinson disease.